Latest Insider Transactions at Relmada Therapeutics, Inc. (RLMD)
This section provides a real-time view of insider transactions for Relmada Therapeutics, Inc. (RLMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RELMADA THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RELMADA THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2021
|
Sergio Traversa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,170
-1.37%
|
$75,950
$35.8 P/Share
|
|
Jan 22
2021
|
Sergio Traversa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,070
+4.87%
|
$12,210
$3.24 P/Share
|
|
Jan 22
2021
|
Paul Edward Kelly Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.69%
|
$3,756,900
$1789.59 P/Share
|
|
Jan 22
2021
|
Paul Edward Kelly Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,085
+2.63%
|
$12,255
$3.24 P/Share
|
|
Jan 04
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-12.02%
|
$96,000
$32.11 P/Share
|
|
Dec 01
2020
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-10.73%
|
$105,000
$35.74 P/Share
|
|
Nov 24
2020
|
Charles J Casamento Director |
SELL
Bona fide gift
|
Direct |
21,223
-43.16%
|
-
|
|
Nov 02
2020
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-5.75%
|
$90,000
$30.29 P/Share
|
|
Oct 01
2020
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-5.44%
|
$111,000
$37.99 P/Share
|